MedPath

Enteral Formula Tolerance of Standard Tube Feedings

Completed
Conditions
Enteral Feeding
Interventions
Other: enteral formula
Registration Number
NCT02312271
Lead Sponsor
Société des Produits Nestlé (SPN)
Brief Summary

This prospective observational study seeks to assess ability to achieve enteral feeding goals with standard tube feeding formulas.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
102
Inclusion Criteria
  • ≥18 years of age
  • Currently tolerating enteral feeding
  • Has enteral access
  • Requires enteral tube feeding to provide 90% or more of their nutritional needs (without the use of modular(s)) for at least 21 days
  • Having obtained his/her and/or his/her legal representative's informed consent.
Exclusion Criteria
  • Condition which contraindicates enteral feeding (i.e. intestinal obstruction)
  • Lack of enteral access
  • Any condition that would contraindicate use of the study product (i.e. need for severe fluid restriction, cow's milk protein allergy, other)
  • Currently participating in another conflicting clinical study that would interfere with anticipated endpoints
  • Judged to be at risk for poor compliance to the study protocol.
  • Lack of informed consent.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
enterally fed adultsenteral formulaadult subjects with established enteral access receiving standard tube feeding formula
Primary Outcome Measures
NameTimeMethod
Daily percentage of caloric nutritional goal met21 days
Secondary Outcome Measures
NameTimeMethod
GI tolerance21 days
Adverse events and serious adverse events21 days
Daily percentage of protein goal met21 days

Trial Locations

Locations (3)

Vanderbilt University

🇺🇸

Nashville, Tennessee, United States

Bruyere Research Institute

🇨🇦

Ottawa, Ontario, Canada

University of Arkansas

🇺🇸

Little Rock, Arkansas, United States

© Copyright 2025. All Rights Reserved by MedPath